BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating UniQure N.V. (NASDAQ: QURE) for potential securities law violations. Investors who have lost money in their UniQure investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/qure. What is this all about? Shares of uniQure fell as much as 66% Monday after the drug developer said the FDA deemed the clinical data for its experimental gene-therapy fo ...